Formulation for respiratory tract administration

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/13 (2006.01) A61K 9/12 (2006.01) A61K 9/72 (2006.01) A61K 31/136 (2006.01)

Patent

CA 2234847

A dosage form for intranasal and/or inhalation administration of an analgesic having low opioid receptor binding activity to a warm blooded animal, that includes a pharmaceutically effective amount of the analgesic. A preferred analgesic is tramadol, a tramadol and/or a pharmaceutically acceptable salt, metabolite or derivative thereof. Methods of making and using the formulation according to the invention are also provided.

L'invention concerne une forme galénique pour l'administration intranasale et/ou par inhalation à un homéotherme d'un analgésique présentant une faible activité de fixation des récepteurs opioïdes. Cette forme galénique contient une dose pharmaceutiquement efficace de l'analgésique. Un analgésique préféré est le tramadol, un tramadol et/ou son sel, métabolite ou dérivé pharmaceutiquement acceptable. L'invention concerne également des procédés de fabrication et d'utilisation de cette formulation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Formulation for respiratory tract administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Formulation for respiratory tract administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation for respiratory tract administration will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1622678

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.